Share Price and Basic Stock Data
Last Updated: March 8, 2025, 1:24 pm
PEG Ratio | 1.57 |
---|
Competitors of Mawana Sugars Ltd
Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
---|---|---|---|---|---|---|---|---|---|
Gayatri Sugars Ltd | 62.1 Cr. | 9.53 | 26.5/9.12 | 19.9 | 0.00 % | 93.2 % | % | 10.0 | |
Dhampure Speciality Sugars Ltd | 78.4 Cr. | 94.1 | 142/75.7 | 47.3 | 35.6 | 0.00 % | 3.15 % | 3.78 % | 10.0 |
Dhampur Bio Organics Ltd | 409 Cr. | 61.8 | 164/58.5 | 37.0 | 146 | 4.05 % | 5.02 % | 3.67 % | 10.0 |
DCM Shriram Industries Ltd | 1,335 Cr. | 153 | 242/143 | 11.5 | 100 | 1.31 % | 16.1 % | 14.9 % | 2.00 |
Davangere Sugar Company Ltd | 408 Cr. | 4.35 | 10.9/4.10 | 30.1 | 3.64 | 0.00 % | 6.86 % | 3.75 % | 1.00 |
Industry Average | 1,809.37 Cr | 255.97 | 20.64 | 224.52 | 0.86% | 12.98% | 13.21% | 6.37 |
Quarterly Result
Metric | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 488 | 294 | 308 | 341 | 482 | 350 | 326 | 381 | 326 | 322 | 387 | 382 | 334 |
Expenses | 454 | 232 | 305 | 368 | 462 | 269 | 330 | 409 | 285 | 241 | 372 | 393 | 305 |
Operating Profit | 33 | 62 | 3 | -27 | 19 | 81 | -3 | -29 | 41 | 81 | 15 | -10 | 29 |
OPM % | 7% | 21% | 1% | -8% | 4% | 23% | -1% | -8% | 13% | 25% | 4% | -3% | 9% |
Other Income | 2 | -2 | -0 | 1 | 1 | 0 | 1 | 26 | 0 | 1 | 1 | 0 | 64 |
Interest | 4 | 7 | 9 | 9 | 4 | 6 | 10 | 7 | 3 | 10 | 13 | 8 | 1 |
Depreciation | 10 | 10 | 9 | 8 | 9 | 9 | 8 | 8 | 9 | 10 | 8 | 8 | 9 |
Profit before tax | 21 | 42 | -15 | -43 | 7 | 66 | -20 | -18 | 29 | 63 | -6 | -27 | 83 |
Tax % | 26% | 27% | -22% | -24% | 26% | 21% | -24% | -38% | 39% | 25% | -21% | -24% | 13% |
Net Profit | 15 | 31 | -12 | -32 | 5 | 52 | -16 | -11 | 18 | 47 | -5 | -20 | 73 |
EPS in Rs | 3.88 | 7.94 | -3.04 | -8.29 | 1.36 | 13.33 | -3.99 | -2.92 | 4.50 | 12.04 | -1.17 | -5.16 | 18.54 |
Last Updated: February 28, 2025, 6:29 pm
Below is a detailed analysis of the quarterly data for Mawana Sugars Ltd based on the most recent figures (Dec 2024) and their trends compared to the previous period:
- For Sales, as of Dec 2024, the value is ₹334.00 Cr.. The value appears to be declining and may need further review. It has decreased from 382.00 Cr. (Sep 2024) to ₹334.00 Cr., marking a decrease of 48.00 Cr..
- For Expenses, as of Dec 2024, the value is ₹305.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 393.00 Cr. (Sep 2024) to ₹305.00 Cr., marking a decrease of 88.00 Cr..
- For Operating Profit, as of Dec 2024, the value is ₹29.00 Cr.. The value appears strong and on an upward trend. It has increased from -10.00 Cr. (Sep 2024) to ₹29.00 Cr., marking an increase of ₹39.00 Cr..
- For OPM %, as of Dec 2024, the value is 9.00%. The value appears strong and on an upward trend. It has increased from -3.00% (Sep 2024) to 9.00%, marking an increase of 12.00%.
- For Other Income, as of Dec 2024, the value is ₹64.00 Cr.. The value appears strong and on an upward trend. It has increased from 0.00 Cr. (Sep 2024) to ₹64.00 Cr., marking an increase of ₹64.00 Cr..
- For Interest, as of Dec 2024, the value is ₹1.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 8.00 Cr. (Sep 2024) to ₹1.00 Cr., marking a decrease of 7.00 Cr..
- For Depreciation, as of Dec 2024, the value is ₹9.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 8.00 Cr. (Sep 2024) to ₹9.00 Cr., marking an increase of ₹1.00 Cr..
- For Profit before tax, as of Dec 2024, the value is ₹83.00 Cr.. The value appears strong and on an upward trend. It has increased from -27.00 Cr. (Sep 2024) to ₹83.00 Cr., marking an increase of ₹110.00 Cr..
- For Tax %, as of Dec 2024, the value is 13.00%. The value appears to be increasing, which may not be favorable. It has increased from -24.00% (Sep 2024) to 13.00%, marking an increase of 37.00%.
- For Net Profit, as of Dec 2024, the value is ₹73.00 Cr.. The value appears strong and on an upward trend. It has increased from -20.00 Cr. (Sep 2024) to ₹73.00 Cr., marking an increase of ₹93.00 Cr..
- For EPS in Rs, as of Dec 2024, the value is 18.54. The value appears strong and on an upward trend. It has increased from ₹-5.16 (Sep 2024) to 18.54, marking an increase of ₹23.70.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: March 7, 2025, 7:31 pm
Metric | Sep 2012n n 18m | Sep 2013 | Dec 2014n n 15m | Mar 2016n n 15m | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sales | 1,799 | 1,342 | 1,399 | 1,485 | 1,191 | 1,344 | 1,165 | 1,161 | 1,469 | 1,478 | 1,482 | 1,355 | 1,426 |
Expenses | 1,779 | 1,398 | 1,452 | 1,379 | 1,022 | 1,301 | 1,050 | 1,109 | 1,372 | 1,373 | 1,405 | 1,265 | 1,311 |
Operating Profit | 21 | -57 | -52 | 106 | 169 | 43 | 115 | 52 | 96 | 105 | 77 | 90 | 115 |
OPM % | 1% | -4% | -4% | 7% | 14% | 3% | 10% | 4% | 7% | 7% | 5% | 7% | 8% |
Other Income | -26 | 30 | 9 | 10 | 356 | 27 | 11 | 17 | 92 | -2 | 2 | 28 | 66 |
Interest | 124 | 91 | 77 | 77 | 51 | 38 | 24 | 27 | 35 | 26 | 28 | 30 | 33 |
Depreciation | 77 | 50 | 61 | 38 | 30 | 24 | 33 | 56 | 48 | 40 | 36 | 35 | 34 |
Profit before tax | -206 | -168 | -181 | 1 | 443 | 7 | 69 | -13 | 105 | 38 | 15 | 53 | 114 |
Tax % | -1% | 1% | 0% | -0% | 19% | -33% | 41% | 521% | 31% | 31% | 14% | 29% | |
Net Profit | -204 | -170 | -181 | 1 | 359 | 10 | 40 | -83 | 73 | 26 | 13 | 38 | 95 |
EPS in Rs | -58.35 | -43.15 | -46.37 | 0.20 | 91.78 | 2.49 | 10.32 | -21.19 | 18.73 | 6.69 | 3.36 | 9.62 | 24.25 |
Dividend Payout % | -0% | -0% | -0% | -0% | -0% | -0% | -0% | -0% | 16% | 45% | 89% | 42% |
YoY Net Profit Growth
Year | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 |
---|---|---|---|---|---|---|---|
YoY Net Profit Growth (%) | -97.21% | 300.00% | -307.50% | 187.95% | -64.38% | -50.00% | 192.31% |
Change in YoY Net Profit Growth (%) | 0.00% | 397.21% | -607.50% | 495.45% | -252.34% | 14.38% | 242.31% |
Mawana Sugars Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 7 years from 2017-2018 to 2023-2024.
Growth
Compounded Sales Growth | |
---|---|
10 Years: | 0% |
5 Years: | 3% |
3 Years: | -3% |
TTM: | 3% |
Compounded Profit Growth | |
---|---|
10 Years: | 8% |
5 Years: | -12% |
3 Years: | 83% |
TTM: | -4% |
Stock Price CAGR | |
---|---|
10 Years: | 26% |
5 Years: | 25% |
3 Years: | -19% |
1 Year: | -10% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | -1% |
3 Years: | 6% |
Last Year: | 5% |
Last Updated: Unknown
Balance Sheet
Last Updated: November 14, 2024, 8:33 pm
Month | Sep 2012 | Sep 2013 | Dec 2014 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 35 | 39 | 39 | 39 | 39 | 39 | 39 | 39 | 39 | 39 | 39 | 39 | 39 |
Reserves | -72 | -245 | -427 | -426 | 292 | 302 | 342 | 257 | 331 | 345 | 345 | 371 | 331 |
Borrowings | 571 | 702 | 504 | 482 | 244 | 143 | 239 | 488 | 276 | 417 | 383 | 568 | 182 |
Other Liabilities | 370 | 394 | 818 | 958 | 588 | 622 | 788 | 689 | 735 | 250 | 266 | 200 | 122 |
Total Liabilities | 903 | 890 | 934 | 1,053 | 1,163 | 1,105 | 1,408 | 1,474 | 1,380 | 1,051 | 1,033 | 1,179 | 675 |
Fixed Assets | 574 | 529 | 474 | 441 | 321 | 313 | 296 | 298 | 232 | 212 | 197 | 204 | 190 |
CWIP | 1 | 1 | 1 | 3 | 4 | 8 | 8 | 1 | 13 | 3 | 16 | 1 | 13 |
Investments | 2 | 0 | 0 | 0 | 0 | 0 | 15 | 13 | 10 | 4 | 3 | 3 | 3 |
Other Assets | 327 | 360 | 460 | 609 | 838 | 784 | 1,089 | 1,161 | 1,126 | 832 | 817 | 972 | 469 |
Total Assets | 903 | 890 | 934 | 1,053 | 1,163 | 1,105 | 1,408 | 1,474 | 1,380 | 1,051 | 1,033 | 1,179 | 675 |
Below is a detailed analysis of the balance sheet data for Mawana Sugars Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2024, the value is ₹39.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded ₹39.00 Cr..
- For Reserves, as of Sep 2024, the value is ₹331.00 Cr.. The value appears to be declining and may need further review. It has decreased from ₹371.00 Cr. (Mar 2024) to ₹331.00 Cr., marking a decrease of 40.00 Cr..
- For Borrowings, as of Sep 2024, the value is ₹182.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from ₹568.00 Cr. (Mar 2024) to ₹182.00 Cr., marking a decrease of 386.00 Cr..
- For Other Liabilities, as of Sep 2024, the value is ₹122.00 Cr.. The value appears to be improving (decreasing). It has decreased from ₹200.00 Cr. (Mar 2024) to ₹122.00 Cr., marking a decrease of 78.00 Cr..
- For Total Liabilities, as of Sep 2024, the value is ₹675.00 Cr.. The value appears to be improving (decreasing). It has decreased from ₹1,179.00 Cr. (Mar 2024) to ₹675.00 Cr., marking a decrease of 504.00 Cr..
- For Fixed Assets, as of Sep 2024, the value is ₹190.00 Cr.. The value appears to be declining and may need further review. It has decreased from ₹204.00 Cr. (Mar 2024) to ₹190.00 Cr., marking a decrease of 14.00 Cr..
- For CWIP, as of Sep 2024, the value is ₹13.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹1.00 Cr. (Mar 2024) to ₹13.00 Cr., marking an increase of 12.00 Cr..
- For Investments, as of Sep 2024, the value is ₹3.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded ₹3.00 Cr..
- For Other Assets, as of Sep 2024, the value is ₹469.00 Cr.. The value appears to be declining and may need further review. It has decreased from ₹972.00 Cr. (Mar 2024) to ₹469.00 Cr., marking a decrease of 503.00 Cr..
- For Total Assets, as of Sep 2024, the value is ₹675.00 Cr.. The value appears to be declining and may need further review. It has decreased from ₹1,179.00 Cr. (Mar 2024) to ₹675.00 Cr., marking a decrease of 504.00 Cr..
Notably, the Reserves (₹331.00 Cr.) exceed the Borrowings (182.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
Month | Sep 2012 | Sep 2013 | Dec 2014 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
Month | Dec 2014n n 15m | Mar 2016n n 15m | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2012n n 18m | Sep 2013 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow | -52.00 | 106.00 | -75.00 | -100.00 | -124.00 | -436.00 | -180.00 | -312.00 | -306.00 | -478.00 | 21.00 | -759.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
Month | Sep 2012 | Sep 2013 | Dec 2014 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 6 | 11 | 13 | 18 | 13 | 14 | 12 | 15 | 10 | 10 | 8 | 11 |
Inventory Days | 56 | 90 | 108 | 165 | 238 | 176 | 417 | 333 | 246 | 214 | 208 | 300 |
Days Payable | 76 | 107 | 225 | 268 | 217 | 204 | 355 | 231 | 201 | 57 | 61 | 52 |
Cash Conversion Cycle | -14 | -5 | -104 | -85 | 34 | -14 | 74 | 117 | 55 | 167 | 155 | 259 |
Working Capital Days | -52 | -63 | -159 | -131 | -18 | -30 | 9 | 67 | 64 | 126 | 119 | 199 |
ROCE % | -5% | -19% | -34% | 73% | 44% | 6% | 17% | 2% | 7% | 10% | 6% | 7% |
This stock is not held by any mutual fund
Key Financial Ratios
Month | Mar 24 | Mar 23 | Mar 22 | Mar 21 | Mar 20 |
---|---|---|---|---|---|
FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
Basic EPS (Rs.) | 9.63 | 3.36 | 6.69 | 18.73 | -21.19 |
Diluted EPS (Rs.) | 9.63 | 3.36 | 6.69 | 18.73 | -21.19 |
Cash EPS (Rs.) | 18.70 | 12.55 | 16.51 | 30.98 | -6.59 |
Book Value[Excl.RevalReserv]/Share (Rs.) | 104.87 | 98.24 | 98.24 | 94.51 | 75.77 |
Book Value[Incl.RevalReserv]/Share (Rs.) | 104.87 | 98.24 | 98.24 | 94.51 | 75.77 |
Revenue From Operations / Share (Rs.) | 346.39 | 378.76 | 377.88 | 375.53 | 296.80 |
PBDIT / Share (Rs.) | 30.22 | 20.55 | 27.77 | 25.55 | 15.73 |
PBIT / Share (Rs.) | 21.19 | 11.44 | 17.63 | 13.39 | 1.53 |
PBT / Share (Rs.) | 13.60 | 3.98 | 9.37 | 32.64 | -5.37 |
Net Profit / Share (Rs.) | 9.66 | 3.44 | 6.37 | 18.82 | -20.79 |
NP After MI And SOA / Share (Rs.) | 9.62 | 3.36 | 6.68 | 18.73 | -21.19 |
PBDIT Margin (%) | 8.72 | 5.42 | 7.34 | 6.80 | 5.30 |
PBIT Margin (%) | 6.11 | 3.02 | 4.66 | 3.56 | 0.51 |
PBT Margin (%) | 3.92 | 1.05 | 2.47 | 8.69 | -1.80 |
Net Profit Margin (%) | 2.78 | 0.90 | 1.68 | 5.01 | -7.00 |
NP After MI And SOA Margin (%) | 2.77 | 0.88 | 1.76 | 4.98 | -7.14 |
Return on Networth / Equity (%) | 9.17 | 3.41 | 6.80 | 19.81 | -27.98 |
Return on Capital Employeed (%) | 19.73 | 11.12 | 15.82 | 11.41 | 1.16 |
Return On Assets (%) | 3.19 | 1.27 | 2.48 | 5.30 | -5.62 |
Long Term Debt / Equity (X) | 0.00 | 0.01 | 0.10 | 0.20 | 0.65 |
Total Debt / Equity (X) | 1.38 | 0.99 | 1.08 | 0.66 | 1.22 |
Asset Turnover Ratio (%) | 1.23 | 1.42 | 1.20 | 1.02 | 0.80 |
Current Ratio (X) | 1.26 | 1.23 | 1.30 | 1.17 | 1.11 |
Quick Ratio (X) | 0.10 | 0.14 | 0.15 | 0.29 | 0.22 |
Inventory Turnover Ratio (X) | 1.59 | 1.71 | 1.49 | 1.43 | 1.24 |
Dividend Payout Ratio (NP) (%) | 31.15 | 89.33 | 44.87 | 0.00 | 0.00 |
Dividend Payout Ratio (CP) (%) | 16.06 | 24.05 | 17.82 | 0.00 | 0.00 |
Earning Retention Ratio (%) | 68.85 | 10.67 | 55.13 | 0.00 | 0.00 |
Cash Earning Retention Ratio (%) | 83.94 | 75.95 | 82.18 | 0.00 | 0.00 |
Interest Coverage Ratio (X) | 3.98 | 2.88 | 4.22 | 2.83 | 2.28 |
Interest Coverage Ratio (Post Tax) (X) | 2.27 | 1.53 | 2.22 | 0.56 | -2.36 |
Enterprise Value (Cr.) | 872.85 | 698.20 | 890.78 | 288.33 | 386.75 |
EV / Net Operating Revenue (X) | 0.64 | 0.47 | 0.60 | 0.19 | 0.33 |
EV / EBITDA (X) | 7.38 | 8.69 | 8.20 | 2.88 | 6.28 |
MarketCap / Net Operating Revenue (X) | 0.24 | 0.23 | 0.35 | 0.09 | 0.07 |
Retention Ratios (%) | 68.84 | 10.66 | 55.12 | 0.00 | 0.00 |
Price / BV (X) | 0.80 | 0.92 | 1.36 | 0.38 | 0.29 |
Price / Net Operating Revenue (X) | 0.24 | 0.23 | 0.35 | 0.09 | 0.07 |
EarningsYield | 0.11 | 0.03 | 0.05 | 0.51 | -0.93 |
After reviewing the key financial ratios for Mawana Sugars Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 24, the value is 9.63. This value is within the healthy range. It has increased from 3.36 (Mar 23) to 9.63, marking an increase of 6.27.
- For Diluted EPS (Rs.), as of Mar 24, the value is 9.63. This value is within the healthy range. It has increased from 3.36 (Mar 23) to 9.63, marking an increase of 6.27.
- For Cash EPS (Rs.), as of Mar 24, the value is 18.70. This value is within the healthy range. It has increased from 12.55 (Mar 23) to 18.70, marking an increase of 6.15.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 104.87. It has increased from 98.24 (Mar 23) to 104.87, marking an increase of 6.63.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 104.87. It has increased from 98.24 (Mar 23) to 104.87, marking an increase of 6.63.
- For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 346.39. It has decreased from 378.76 (Mar 23) to 346.39, marking a decrease of 32.37.
- For PBDIT / Share (Rs.), as of Mar 24, the value is 30.22. This value is within the healthy range. It has increased from 20.55 (Mar 23) to 30.22, marking an increase of 9.67.
- For PBIT / Share (Rs.), as of Mar 24, the value is 21.19. This value is within the healthy range. It has increased from 11.44 (Mar 23) to 21.19, marking an increase of 9.75.
- For PBT / Share (Rs.), as of Mar 24, the value is 13.60. This value is within the healthy range. It has increased from 3.98 (Mar 23) to 13.60, marking an increase of 9.62.
- For Net Profit / Share (Rs.), as of Mar 24, the value is 9.66. This value is within the healthy range. It has increased from 3.44 (Mar 23) to 9.66, marking an increase of 6.22.
- For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 9.62. This value is within the healthy range. It has increased from 3.36 (Mar 23) to 9.62, marking an increase of 6.26.
- For PBDIT Margin (%), as of Mar 24, the value is 8.72. This value is below the healthy minimum of 10. It has increased from 5.42 (Mar 23) to 8.72, marking an increase of 3.30.
- For PBIT Margin (%), as of Mar 24, the value is 6.11. This value is below the healthy minimum of 10. It has increased from 3.02 (Mar 23) to 6.11, marking an increase of 3.09.
- For PBT Margin (%), as of Mar 24, the value is 3.92. This value is below the healthy minimum of 10. It has increased from 1.05 (Mar 23) to 3.92, marking an increase of 2.87.
- For Net Profit Margin (%), as of Mar 24, the value is 2.78. This value is below the healthy minimum of 5. It has increased from 0.90 (Mar 23) to 2.78, marking an increase of 1.88.
- For NP After MI And SOA Margin (%), as of Mar 24, the value is 2.77. This value is below the healthy minimum of 8. It has increased from 0.88 (Mar 23) to 2.77, marking an increase of 1.89.
- For Return on Networth / Equity (%), as of Mar 24, the value is 9.17. This value is below the healthy minimum of 15. It has increased from 3.41 (Mar 23) to 9.17, marking an increase of 5.76.
- For Return on Capital Employeed (%), as of Mar 24, the value is 19.73. This value is within the healthy range. It has increased from 11.12 (Mar 23) to 19.73, marking an increase of 8.61.
- For Return On Assets (%), as of Mar 24, the value is 3.19. This value is below the healthy minimum of 5. It has increased from 1.27 (Mar 23) to 3.19, marking an increase of 1.92.
- For Long Term Debt / Equity (X), as of Mar 24, the value is 0.00. This value is below the healthy minimum of 0.2. It has decreased from 0.01 (Mar 23) to 0.00, marking a decrease of 0.01.
- For Total Debt / Equity (X), as of Mar 24, the value is 1.38. This value exceeds the healthy maximum of 1. It has increased from 0.99 (Mar 23) to 1.38, marking an increase of 0.39.
- For Asset Turnover Ratio (%), as of Mar 24, the value is 1.23. It has decreased from 1.42 (Mar 23) to 1.23, marking a decrease of 0.19.
- For Current Ratio (X), as of Mar 24, the value is 1.26. This value is below the healthy minimum of 1.5. It has increased from 1.23 (Mar 23) to 1.26, marking an increase of 0.03.
- For Quick Ratio (X), as of Mar 24, the value is 0.10. This value is below the healthy minimum of 1. It has decreased from 0.14 (Mar 23) to 0.10, marking a decrease of 0.04.
- For Inventory Turnover Ratio (X), as of Mar 24, the value is 1.59. This value is below the healthy minimum of 4. It has decreased from 1.71 (Mar 23) to 1.59, marking a decrease of 0.12.
- For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 31.15. This value is within the healthy range. It has decreased from 89.33 (Mar 23) to 31.15, marking a decrease of 58.18.
- For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 16.06. This value is below the healthy minimum of 20. It has decreased from 24.05 (Mar 23) to 16.06, marking a decrease of 7.99.
- For Earning Retention Ratio (%), as of Mar 24, the value is 68.85. This value is within the healthy range. It has increased from 10.67 (Mar 23) to 68.85, marking an increase of 58.18.
- For Cash Earning Retention Ratio (%), as of Mar 24, the value is 83.94. This value exceeds the healthy maximum of 70. It has increased from 75.95 (Mar 23) to 83.94, marking an increase of 7.99.
- For Interest Coverage Ratio (X), as of Mar 24, the value is 3.98. This value is within the healthy range. It has increased from 2.88 (Mar 23) to 3.98, marking an increase of 1.10.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 2.27. This value is below the healthy minimum of 3. It has increased from 1.53 (Mar 23) to 2.27, marking an increase of 0.74.
- For Enterprise Value (Cr.), as of Mar 24, the value is 872.85. It has increased from 698.20 (Mar 23) to 872.85, marking an increase of 174.65.
- For EV / Net Operating Revenue (X), as of Mar 24, the value is 0.64. This value is below the healthy minimum of 1. It has increased from 0.47 (Mar 23) to 0.64, marking an increase of 0.17.
- For EV / EBITDA (X), as of Mar 24, the value is 7.38. This value is within the healthy range. It has decreased from 8.69 (Mar 23) to 7.38, marking a decrease of 1.31.
- For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 0.24. This value is below the healthy minimum of 1. It has increased from 0.23 (Mar 23) to 0.24, marking an increase of 0.01.
- For Retention Ratios (%), as of Mar 24, the value is 68.84. This value is within the healthy range. It has increased from 10.66 (Mar 23) to 68.84, marking an increase of 58.18.
- For Price / BV (X), as of Mar 24, the value is 0.80. This value is below the healthy minimum of 1. It has decreased from 0.92 (Mar 23) to 0.80, marking a decrease of 0.12.
- For Price / Net Operating Revenue (X), as of Mar 24, the value is 0.24. This value is below the healthy minimum of 1. It has increased from 0.23 (Mar 23) to 0.24, marking an increase of 0.01.
- For EarningsYield, as of Mar 24, the value is 0.11. This value is below the healthy minimum of 5. It has increased from 0.03 (Mar 23) to 0.11, marking an increase of 0.08.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
Strength | Weakness |
---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Mawana Sugars Ltd:
- Net Profit Margin: 2.78%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 19.73% (Industry Average ROCE: 12.98%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 9.17% (Industry Average ROE: 13.21%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 2.27
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.1
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 8.32 (Industry average Stock P/E: 20.64)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 1.38
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 2.78%
About the Company - Qualitative Analysis
INDUSTRY | ADDRESS | CONTACT |
---|---|---|
Industry not found | Address not found | Contact not found |
FAQ
What is the latest intrinsic value of Mawana Sugars Ltd?
The latest intrinsic value of Mawana Sugars Ltd as on 08 March 2025 is ₹35.35, which is 59.88% lower than the current market price of 88.10, indicating the stock is overvalued by 59.88%. The intrinsic value of Mawana Sugars Ltd is calculated using PE ratio method. The stock has a market capitalization of ₹345 Cr. and recorded a high/low of ₹137/78.4 during the current fiscal year 2024-2025. As of Sep 2024, the company has reserves of ₹331 Cr and total liabilities of ₹675 Cr.
What is the Market Cap of Mawana Sugars Ltd?
The Market Cap of Mawana Sugars Ltd is 345 Cr..
What is the current Stock Price of Mawana Sugars Ltd as on 08 March 2025?
The current stock price of Mawana Sugars Ltd as on 08 March 2025 is ₹88.1.
What is the High / Low of Mawana Sugars Ltd stocks in FY 2024-2025?
In FY 2024-2025, the High / Low of Mawana Sugars Ltd stocks is ₹137/78.4.
What is the Stock P/E of Mawana Sugars Ltd?
The Stock P/E of Mawana Sugars Ltd is 8.32.
What is the Book Value of Mawana Sugars Ltd?
The Book Value of Mawana Sugars Ltd is 94.6.
What is the Dividend Yield of Mawana Sugars Ltd?
The Dividend Yield of Mawana Sugars Ltd is 4.54 %.
What is the ROCE of Mawana Sugars Ltd?
The ROCE of Mawana Sugars Ltd is 6.84 %.
What is the ROE of Mawana Sugars Ltd?
The ROE of Mawana Sugars Ltd is 5.37 %.
What is the Face Value of Mawana Sugars Ltd?
The Face Value of Mawana Sugars Ltd is 10.0.